All Pharma News
Equillium is no longer buying Metacrine, citing new cash

Equillium is no longer buying Metacrine, citing new cash
Max Bayer FIERCEBIOTECH
27 Dec 2022
Share Share
Metacrine and Equillium Mutually Agree to Terminate Definitive Merger Agreement

Metacrine and Equillium Mutually Agree to Terminate Definitive Merger Agreement
GLOBENEWSWIRE
23 Dec 2022
Share Share
Equillium to Acquire Metacrine in All-Stock Transaction

Equillium to Acquire Metacrine in All-Stock Transaction
BUSINESSWIRE
06 Sep 2022
Share Share
Metacrine Reports First-Quarter 2022 Results

Metacrine Reports First-Quarter 2022 Results
GLOBENEWSWIRE
12 May 2022
Share Share
Metacrine Reports Fourth-Quarter 2021 Results

Metacrine Reports Fourth-Quarter 2021 Results
GLOBENEWSWIRE
30 Mar 2022
Share Share
Metacrine Announces Executive Leadership Changes

Metacrine Announces Executive Leadership Changes
GLOBENEWSWIRE
24 Feb 2022
Share Share
Metacrine lays off 50% of staff, axes more R&D to focus on IBD

Metacrine lays off 50% of staff, axes more R&D to focus on IBD
FIERCEBIOTECH
11 Feb 2022
Share Share
Metacrine Reports Third-Quarter 2021 Results

Metacrine Reports Third-Quarter 2021 Results
GLOBENEWSWIRE
11 Nov 2021
Share Share
Metacrine shares halved as NASH work thrown out

Metacrine shares halved as NASH work thrown out
Chris Wack MARKETWATCH
23 Oct 2021
Share Share
Metacrine Reports Interim Results for MET642 Phase 2a Trial inPatients with NASH

Metacrine Reports Interim Results for MET642 Phase 2a Trial inPatients with NASH
GLOBENEWSWIRE
21 Oct 2021
Share Share